The post‐PET immunohistochemistry confirmed a significant reduction of IL‐1β and TNF‐α in the AD brain, especially in the cortex and hippocampus after EA treatment (Figure S8 in supporting information). The gene discussed is IL1B; the disease is Alzheimer disease.